Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)

Hospital


Location: Lausanne, Switzerland (CH) CH

ISNI: 0000000104234662

ROR: https://ror.org/05a353079

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response (2021) Dimitriou F, Zaremba A, Allayous C, Kähler KC, Gerard CL, Festino L, Schäfer S, et al. Journal article Consensus on molecular imaging and theranostics in neuroendocrine neoplasms (2021) Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, et al. Journal article, Review article Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury (2021) Squair JW, Gautier M, Mahe L, Soriano JE, Rowald A, Bichat A, Cho N, et al. Journal article The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors: Results from phase 3 of the RAISE project (2021) Pavel ME, Dromain C, Ronot M, Schaefer N, Mandair D, Gueguen D, Elvira D, et al. Conference contribution Dissociated response as a new biomarker of treatment response in neuroendocrine tumors: Results from phase 3 of the RAISE project (2021) Dromain C, Pavel ME, Ronot M, Schaefer N, Mandair D, Gueguen D, Cheng C, et al. Conference contribution Outcome Prognostication of Acute Brain Injury using the Neurological Pupil Index (ORANGE) study: protocol for a prospective, observational, multicentre, international cohort study. (2021) Oddo M, Taccone F, Galimberti S, Rebora P, Citerio G Journal article ENETS consensus guidelines for synoptic reporting of radiology studies (2021) Dromain C, Vullierme MP, Hicks RJ, Prasad V, O'Toole D, De Herder WW, Pavel ME, et al. Journal article PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021) Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al. Conference contribution Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section (2021) Ng S, Messerer M, Engelhardt J, Bruneau M, Cornelius JF, Cavallo LM, Cossu G, et al. Journal article, Review article Correction to: Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome (Journal of Neurology, (2020), 267, 7, (2101-2114), 10.1007/s00415-020-09814-3) (2021) Bien CG, Bien CI, Onugoren MD, De Simoni D, Eigler V, Haensch CA, Holtkamp M, et al. Journal article, Erratum